✦ LIBER ✦

Avagacestat (BMS-708163) exposures and study discontinuations in patients with mild-to-moderate Alzheimer's disease

✍ Scribed by AbuTarif, Malaz; Kaplita, Stephen; Berman, Robert; Coric, Vlad; Colby, Susan; Baron, Kyle

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and tolerability of BMS-708163 in

✍ Salloway, Stephen; Coric, Vlad; Brody, Mark; Andreasen, Niels; van Dyck, Christo 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Safety and tolerability of avagacestat (

✍ Preston, Jeanette; Berman, Robert; Kaplita, Stephen; Gandhi, Kunal K.; Lipschitz 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Cerebral microbleeds in a phase 2 clinic

✍ Feldman, Howard; Coric, Vlad; Sperling, Reisa; Greenberg, Steven; Bronen, Richar 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

The gamma-secretase inhibitor BMS-708163

✍ Charles Albright; Niels Andreasen; Lennart Minthon; Kaj Blennow; Howard Feldman; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Apraxic disturbances in patients with mi

✍ Christian Derouesné; Samira Lagha-Pierucci; Stéphanie Thibault; Véronique Baudou 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Baseline clinical scores and volumetric

✍ Luc Bracoud; Vlad Coric; Christopher van Dyck; Neils Andreasen; Joel Ross; Mark 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 137 KB